Fig. 5
Forest plot showing the effect of glucagon-like peptide-1 (GLP-1) receptor agonists on urinary albumin-to-creatinine ratio in terms of the weighted mean difference and 95% fiducial intervals
Fig. 5 | BMC Endocrine Disorders